NewSPACInsider launches AI-powered access to its SPAC databaseLearn more →

Archive

May 2023
2023
JanFebMarApr
MayJunJulAug
SepOctNovDec

Wed, May 31

Latest

The Latest SPAC News and Rumors: May 31, 2023

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: eureKING signs put option for the potential acquisition of Skyepharma and Pear Therapeutics sells for $6M in post-bankruptcy auction  eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader eureKING (ISIN: FR0014009ON9, Euronext Paris), the first European SPAC in healthcare dedicated to bioproduction, today announced that it has signed, on May 25, 2023, a put option agreement for 100% of the share capital of Oleron Pharma, the 100% holding company of Skyepharma. More
Marlena Haddad·SPACs in the News

Tue, May 30

Wejo (WEJO) Files for Insolvency in UK

Vehicle data-tracker Wejo (NASDAQ:WEJO) announced in an 8-K this afternoon that it has filed its intention to appoint an administrator to oversee its insolvency and it is evaluating whether it will do so in the United States as well. More
Nicholas Alan Clayton·Deal Announcements

New SPAC: Aimei Health Technology Co. Files for $50M IPO

Aimei Health Technology Co.  (NASDAQ:AFJK) filed its S-1 Friday afternoon for a $50 million IPO, marking the fourth SPAC to file for an IPO in May and the twelfth year-to-date. Given its name, it comes as no surprise that Aimei Health Technology intends to pursue prospective targets that are focused on healthcare innovation. More
Marlena Haddad·New S-1 Filings

The Latest SPAC News and Rumors: May 30, 2023

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: GreenLight Biosciences returns to private market, Jet.AI partners with Vegas Golden Knights and Cirrus Aviation, and True Velocity announces partnership with FN America GreenLight returns to private market in $46M deal after taste of Wall Street GreenLight Biosciences will seek its dream off Wall Street in a go-private deal less than two years after taking the special purpose acquisition company route there. More
Marlena Haddad·SPACs in the News